β-synuclein Antibodies

Santa Cruz Biotechnology features a diverse variety of β-synuclein monoclonal antibodies for investigating β-synuclein in various biological processes. β-synuclein monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). β-synuclein is a member of the synuclein family of proteins, primarily expressed in the brain and implicated in neurodegenerative diseases. β-synuclein plays a crucial role in synaptic function and neurotransmitter release, and its dysregulation has been associated with conditions such as Parkinson's disease and Alzheimer's disease. Understanding β-synuclein function is essential for elucidating the mechanisms underlying these disorders and developing potential therapeutic strategies. β-synuclein research has revealed significant insights into neurological function and disease progression. Advanced research techniques have enabled scientists to better understand β-synuclein's role in maintaining healthy brain function. Ongoing studies continue to uncover new aspects of β-synuclein's involvement in cellular processes. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of neurodegenerative diseases and potential treatments.